The Immunoreactivity of Radiolabeled Antibodies—Its Impact on Tumor Targeting and Strategies for Preservation
Author:
- 1 December 2004
- journal article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 19 (6) , 669-672
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- In vitro and in vivo behavior of radiolabeled chimeric anti-EGFRvIII monoclonal antibody: Comparison with its murine parentNuclear Medicine and Biology, 1997
- Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivityMolecular Immunology, 1995
- Problems of Delivery of Monoclonal AntibodiesClinical Pharmacokinetics, 1995
- In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49Nuclear Medicine and Biology, 1995
- Immunoscintigraphy of human colon cancer xenografts in nude mice using a second-generation TAG-72 monoclonal antibody labelled with 99TcmNuclear Medicine Communications, 1994
- Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigenNuclear Medicine and Biology, 1994
- Approaches to Radiolabeling of Antibodies for Diagnosis and Therapy of CancerPharmaceutical Research, 1988
- Comparative tumour localization properties of radiolabelled monoclonal antibody preparations of defined immunoreactivitiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1987
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949